CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,502 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03083769
NCT03083769N/ACompleted
CompareCT.gov

Functional Genetic Variants Affecting Tacrolimus Trough Levels and Side Effects in Chinese Renal Transplantation.

Southern Medical University, China·observational·Posted Mar 20, 2017·Updated Nov 20, 2019

In Brief

An observational study for Transplantation. Completed, enrolled 1,502 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine whether functional genetic variants can affect tacrolimus dose corrected trough levels and associate with the side effects in Chinese renal transplant recipients.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsTransplantation
CountriesChina
CollaboratorsThird Affiliated Hospital, Sun Yat-Sen University, 181 Central Hospital of the Chinese PLA

Timeline

N/ACompletedFinished
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 20, 2017
Enrollment StartJan 1, 1998
Primary CompletionJul 30, 2019
Study CompletionAug 1, 2019
TodayJul 2, 2026
Enrollment to primary: 21.6 yearsPosted 9.3 years ago